Abstract
Stem cell antigen-1 (Sca-1) is the first identified member of mouse Ly6 gene family. We discovered that Sca-1 disrupts TGFβ signaling and enhances mammary tumorigenesis in a DMBA-induced mammary tumor model. Sca-1 gene is lost during evolution in humans. Human Ly6 genes Ly6D, LyE, LyH, and LyK on human chromosome 8q24.3 genes are syntenic to the mouse chromosome 15 where Sca-1 is located. We found that Ly6D, E, H, and K are upregulated in human cancer compared to normal tissue and that the increased expression of these genes are associated with poor prognosis of multiple types of human cancer. Several other groups have indicated increased expression of Ly6 genes in human cancer. Here we described the relevance of expression of human Ly6D, LyE, LyH, and LyK in functioning of normal tissues and tumor progression.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Yutoku, M., Grossberg, A. L., & Pressman, D. (1974). A cell surface antigenic determinant present on mouse plasmacytes and only about half of mouse thymocytes. Journal of Immunology, 112(5), 1774–1781.
Dall, G. V., et al. (2017). SCA-1 labels a subset of estrogen-responsive bipotential repopulating cells within the CD24(+) CD49f(hi) mammary stem cell-enriched compartment. Stem Cell Reports, 8(2), 417–431.
Ceder, J. A., Aalders, T. W., & Schalken, J. A. (2017). Label retention and stem cell marker expression in the developing and adult prostate identifies basal and luminal epithelial stem cell subpopulations. Stem Cell Research & Therapy, 8(1), 95.
Zakaria, N., et al. (2018). Inhibition of NF-kappaB signaling reduces the stemness characteristics of lung cancer stem cells. Frontiers in Oncology, 8, 166.
Upadhyay, G., et al. (2011). Stem cell antigen-1 enhances tumorigenicity by disruption of growth differentiation factor-10 (GDF10)-dependent TGF-beta signaling. Proceedings of the National Academy of Sciences of the United States of America, 108(19), 7820–7825.
Loughner, C. L., et al. (2016). Organization, evolution and functions of the human and mouse Ly6/uPAR family genes. Human Genomics, 10, 10.
Thul, P. J., et al. (2017). A subcellular map of the human proteome. Science, 356(6340), eaal3321.
Uhlen, M., et al. (2015). Proteomics. Tissue-based map of the human proteome. Science, 347(6220), 1260419.
Uhlen, M., et al. (2017). A pathology atlas of the human cancer transcriptome. Science, 357(6352), eaan2507.
Hughes, M., et al. (2013). Ly6e expression is restricted to syncytiotrophoblast cells of the mouse placenta. Placenta, 34(9), 831–835.
Puddifoot, C. A., et al. (2015). Ly6h regulates trafficking of alpha7 nicotinic acetylcholine receptors and nicotine-induced potentiation of glutamatergic signaling. The Journal of Neuroscience, 35(8), 3420–3430.
Fujihara, Y., Okabe, M., & Ikawa, M. (2014). GPI-anchored protein complex, LY6K/TEX101, is required for sperm migration into the oviduct and male fertility in mice. Biology of Reproduction, 90(3), 60.
Rhodes, D. R., et al. (2004). ONCOMINE: A cancer microarray database and integrated data-mining platform. Neoplasia, 6(1), 1–6.
Cancer Genome Atlas Research Network, et al. (2013). The cancer genome atlas pan-cancer analysis project. Nature Genetics, 45(10), 1113–1120.
Luo, L., et al. (2016). Distinct lymphocyte antigens 6 (Ly6) family members Ly6D, Ly6E, Ly6K and Ly6H drive tumorigenesis and clinical outcome. Oncotarget, 7(10), 11165–11193.
Nagy, A., et al. (2018). Validation of miRNA prognostic power in hepatocellular carcinoma using expression data of independent datasets. Scientific Reports, 8(1), 9227.
Mayama, A., et al. (2018). OLFM4, LY6D and S100A7 as potent markers for distant metastasis in estrogen receptor-positive breast carcinoma. Cancer Science, 109(10), 3350–3359.
Colnot, D. R., et al. (2004). Clinical significance of micrometastatic cells detected by E48 (Ly-6D) reverse transcription-polymerase chain reaction in bone marrow of head and neck cancer patients. Clinical Cancer Research, 10(23), 7827–7833.
Dhawan, D., et al. (2018). Naturally-occurring canine invasive urothelial carcinoma harbors luminal and basal transcriptional subtypes found in human muscle invasive bladder cancer. PLoS Genetics, 14(8), e1007571.
Lv, Y., et al. (2018). Overexpression of lymphocyte antigen 6 complex, locus E in gastric cancer promotes cancer cell growth and metastasis. Cellular Physiology and Biochemistry, 45(3), 1219–1229.
Kondoh, N., et al. (1999). Identification and characterization of genes associated with human hepatocellular carcinogenesis. Cancer Research, 59(19), 4990–4996.
Gou, S., et al. (2007). Establishment of clonal colony-forming assay for propagation of pancreatic cancer cells with stem cell properties. Pancreas, 34(4), 429–435.
Bresson-Mazet, C., Gandrillon, O., & Gonin-Giraud, S. (2008). Stem cell antigen 2: A new gene involved in the self-renewal of erythroid progenitors. Cell Proliferation, 41(5), 726–738.
Kim, Y. S., et al. (2016). miRNAs involved in LY6K and estrogen receptor alpha contribute to tamoxifen-susceptibility in breast cancer. Oncotarget, 7(27), 42261–42273.
Kong, H. K., et al. (2016). Epigenetic activation of LY6K predicts the presence of metastasis and poor prognosis in breast carcinoma. Oncotarget, 7(34), 55677–55689.
Zhang, B., et al. (2012). Serological antibodies against LY6K as a diagnostic biomarker in esophageal squamous cell carcinoma. Biomarkers, 17(4), 372–378.
Ambatipudi, S., et al. (2012). Genome-wide expression and copy number analysis identifies driver genes in gingivobuccal cancers. Genes, Chromosomes & Cancer, 51(2), 161–173.
Matsuda, R., et al. (2011). LY6K is a novel molecular target in bladder cancer on basis of integrate genome-wide profiling. British Journal of Cancer, 104(2), 376–386.
Ishikawa, N., et al. (2007). Cancer-testis antigen lymphocyte antigen 6 complex locus K is a serologic biomarker and a therapeutic target for lung and esophageal carcinomas. Cancer Research, 67(24), 11601–11611.
Reese, J. T., et al. (2001). Downregulated expression of Ly-6-ThB on developing T cells marks CD4+CD8+ subset undergoing selection in the thymus. Developmental Immunology, 8(2), 107–121.
Brakenhoff, R. H., et al. (1995). The human E48 antigen, highly homologous to the murine Ly-6 antigen ThB, is a GPI-anchored molecule apparently involved in keratinocyte cell-cell adhesion. The Journal of Cell Biology, 129(6), 1677–1689.
AlHossiny, M., et al. (2016). Ly6E/K signaling to TGFbeta promotes breast cancer progression, immune escape, and drug resistance. Cancer Research, 76(11), 3376–3386.
Yeom, C. J., et al. (2016). LY6E: A conductor of malignant tumor growth through modulation of the PTEN/PI3K/Akt/HIF-1 axis. Oncotarget, 7(40), 65837–65848.
Mar, K. B., et al. (2018). LY6E mediates an evolutionarily conserved enhancement of virus infection by targeting a late entry step. Nature Communications, 9(1), 3603.
Yu, J., Liang, C., & Liu, S. L. (2017). Interferon-inducible LY6E protein promotes HIV-1 infection. The Journal of Biological Chemistry, 292(11), 4674–4685.
Xu, X., et al. (2014). IFN-stimulated gene LY6E in monocytes regulates the CD14/TLR4 pathway but inadequately restrains the hyperactivation of monocytes during chronic HIV-1 infection. Journal of Immunology, 193(8), 4125–4136.
Langford, M. B., et al. (2018). Deletion of the Syncytin A receptor Ly6e impairs syncytiotrophoblast fusion and placental morphogenesis causing embryonic lethality in mice. Scientific Reports, 8(1), 3961.
Bacquin, A., et al. (2017). A cell fusion-based screening method identifies Glycosylphosphatidylinositol-anchored protein Ly6e as the receptor for mouse endogenous retroviral envelope Syncytin-A. Journal of Virology, 91(18), e00832-17.
Liao, X. H., Xie, Z., & Guan, C. N. (2018). MiRNA-500a-3p inhibits cell proliferation and invasion by targeting lymphocyte antigen 6 complex locus K (LY6K) in human non-small cell lung cancer. Neoplasma, 65(5), 673–682.
Kong, H. K., Yoon, S., & Park, J. H. (2012). The regulatory mechanism of the LY6K gene expression in human breast cancer cells. The Journal of Biological Chemistry, 287(46), 38889–38900.
Endo, S., et al. (2016). TEX101, a glycoprotein essential for sperm fertility, is required for stable expression of Ly6k on testicular germ cells. Scientific Reports, 6, 23616.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2019 Springer Nature Switzerland AG
About this chapter
Cite this chapter
Upadhyay, G. (2019). Emerging Role of Novel Biomarkers of Ly6 Gene Family in Pan Cancer. In: Rhim, J., Dritschilo, A., Kremer, R. (eds) Human Cell Transformation. Advances in Experimental Medicine and Biology, vol 1164. Springer, Cham. https://doi.org/10.1007/978-3-030-22254-3_4
Download citation
DOI: https://doi.org/10.1007/978-3-030-22254-3_4
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-030-22253-6
Online ISBN: 978-3-030-22254-3
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)